Coroner warning over bed blocking after woman dies
A report found Dorothy Reid chose not to return to the Queen Elizabeth the Queen Mother Hospital (QEQM), in Margate, when an ambulance was called on 31 March, 2024, after symptoms relating to her broken back worsened.
Mrs Wood said Ms Reid had been left in a chair overnight when she first visited the hospital 10 days earlier, and had she returned, may not have died when she did.
East Kent Hospitals University NHS Foundation Trust (EKHUFT), which runs the QEQM, has apologised for Ms Reid's "difficult experience".
Ms Reid had a fall on 13 March and was treated for a head wound in a minor injuries unit before being sent home.
She was then sent for an X-ray on 21 March, which revealed fractures to her spine.
Ms Reid was referred to the emergency department at QEQM, where she spent the night in a chair because there were no available beds.
Doctors discharged her from hospital and gave her advice on how to keep mobile.
On 31 March, Ms Reid's daughter contacted the 111 service and an ambulance was called after she had complained of shortness of breath accompanied by swollen feet and lower legs.
"Although the ambulance crew advised she should attend hospital, she wanted to avoid a trip to hospital due to her previously having to wait in discomfort for hours," the report stated.
She was seen by a GP the following day and told to call an ambulance if her condition deteriorated.
On 2 April, Ms Reid was taken to hospital but left in the waiting room again as the department was busy.
She deteriorated further and was taken to the resuscitation department, where she had a heart attack.
Ms Reid died shortly after 03:30 BST on 3 April.
Her cause of death was recorded as a blood clot which developed during her reduced mobility because of the fall.
The fall also caused spinal fractures due, in part, to underlying osteoporosis.
The report stated: "Had she gone to hospital on 31 March 2024 when advised to do so, it is likely her pulmonary embolus would have been diagnosed in the emergency department and treated, and she would not have died when she did."
The coroner said beds "blocked by patients fit for discharge" put pressure on emergency departments.
NHS England has previously said roughly 96% of hospital beds were full, with one in seven beds taken by patients who were medically fit to be discharged.
A Department of Health and Social Care spokesperson said: "We will tackle delayed discharges by improving links between the NHS and social care, shifting the focus of care from hospital to community."
EKHUFT said: "We are sorry Dorothy had such a difficult experience in our emergency department last March, which falls way below the standard we want for our patients.
"We extend our condolences to Dorothy's family."
With additional reporting from PA media.
Follow BBC Kent on Facebook, on X and on Instagram. Send your story ideas to southeasttoday@bbc.co.uk or WhatsApp us on 08081 002250.
Woman stuck for 18 months on an NHS ward evicted from her hospital bed
How Lancashire is reducing hospital bed blocking
'Priority' to unblock beds in Sussex hospitals
East Kent Hospitals University NHS Foundation Trust

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
7 hours ago
- Yahoo
Pictures of 'zombie-rabbits' with twisting black horns go viral - so are they real?
Photos of rabbits in Colorado with black, horn-like growths around their faces have gone viral, with some describing the animals as "Frankenstein-", "zombie-" and "demon-rabbits". Warning: This article contains images of infected rabbits, which some readers may find disturbing. Residents in Fort Collins near Denver recently began posting pictures of the cottontail bunnies, causing a stir online. "This is how the zombie virus starts," posted one Instagram user on a post showing the rabbits. "We've got freaking zombie rabbits now?!" posted another on YouTube. So what's going on? Firstly, the pictures are real - despite some wishing they weren't. "One time I need this to be AI," wrote one Instagram user on a post showing the horned bunnies. The rabbits are suffering from a relatively harmless disease called Shope Papilloma Virus, according to Colorado Parks and Wildlife. Although the wildlife agency is getting calls from people spotting the infected rabbits in Fort Collins, they're not an unusual sight, according to spokesperson Kara Van Hoose. The disease is mainly found in America's Midwest, according to the University of Missouri, and is more noticeable in the summer, when the fleas and ticks that spread the virus are most active. The virus can also spread through rabbit-to-rabbit contact but not to other species like humans or dogs and cats, according to Ms Van Hoose. People are being warned not to touch the infected rabbits, however. Read more like this: Do the growths hurt the rabbits? The horn-like growths, or papillomas, are harmless to the bunnies, unless they grow on sensitive areas like the eyes or mouth or interfere with eating. Once the rabbits' immune systems have fought the virus, the growths will disappear. Although infected wild rabbits usually don't need treatment, it can be dangerous to pet rabbits, so officials recommend getting pet bunnies treated by a vet. The mythical jackalope It's not a new illness, and is even thought to have inspired the centuries-old myth of the "jackalope", a rabbit with antelope antlers. Although hunters had long known about the disease, it was first scientifically reported in 1931 by Richard E Shope - hence the name. Since then, the rabbits' warts and horns have contributed to life-saving scientific understanding, including how viruses can be linked to cancer, like the HPV virus to cervical cancer.


CNBC
13 hours ago
- CNBC
Struggling to focus? It could be 'popcorn brain': What it means and how to fix it, from a Harvard doctor and stress expert
Nearly everyone is overloaded with information these days. In each minute of every day, 138.9 million reels are played on Instagram and Facebook, according to a 2024 report by Domo called "Data Never Sleeps." Consuming this much content on a daily basis has shown to have negative effects on a person's ability to focus. Since 2004, psychologist Gloria Mark has studied attention spans, and her research shows that people's attention when viewing a screen decreased from an average of two and half minutes in 2004 to an average of 47 seconds in 2016 — which is about the length of many videos on social media. But the impacts don't stop there. In Harvard physician Dr. Aditi Nerurkar's book, "The 5 Resets: Rewire Your Brain and Body for Less Stress and More Resilience," she discusses yet another side effect of information overload: "popcorn brain." Popcorn brain is when "our brains get habituated to this constant streaming of information, making it harder for us to look away and disconnect from our devices, slow down our thoughts, and live fully offline," Nerurkar wrote in her book. "While not a true medical diagnosis, popcorn brain is a growing cultural phenomenon." Here's how to gain more control over what you're consuming, and shift your popcorn brain. The concept of popcorn brain was created by researcher David Levy in 2011, and it can look like staying up-to-date with the news to frequently checking your social media to see who's engaging with what you're sharing. The overload of information can lower your productivity levels, affect your memory and cause you to feel more stressed. To get out of the loop of picking up your phone every few minutes, and ditch your popcorn brain, Nerurkar suggests four practices: Ditching your smartphone won't be easy when you first start, she acknowledged. It's important to have helpful alternatives for when you want to reach for your phone like a notepad, a fidget toy, a book or a quick exercise like walking around the room. "Rewiring your brain and overcoming your primal urge to scroll is a major feat," Nerurkar said. "In time, your stress will thank you because you'll be deciding who and what gets your attention, not a device in the palm of your hand."


Business Upturn
a day ago
- Business Upturn
Global High-Throughput Screening Market to Surpass USD 50.2 Billion by 2029
By GlobeNewswire Published on August 13, 2025, 05:30 IST Delray Beach, FL, Aug. 12, 2025 (GLOBE NEWSWIRE) — North America Leads Today, Asia Pacific to Record Fastest Growth The global high throughput screening market, valued at US$25.7 billion in 2023, stood at US$28.8 billion in 2024 and is projected to advance at a resilient CAGR of 11.8% from 2024 to 2029, culminating in a forecasted valuation of US$50.2 billion by the end of the period. This growth is propelled by surging R&D investments in drug discovery, strategic government funding, and the increasing adoption of automation in life sciences research. Download PDF Brochure: What Is Driving the Market Now? HTS adoption is accelerating due to innovations in automation, miniaturization, and high-content screening, which significantly reduce discovery timelines and enhance precision in identifying therapeutic candidates. Grants such as the USD 7.8 million awarded to the University of Pittsburgh for advanced drug discovery systems underscore growing institutional and government commitment to high-impact research. Why Does This Matter for Global Pharma and Biotech Leaders? The market represents a critical enabler for competitive advantage in lead discovery, target validation, compound profiling, and hit identification—processes essential for pipeline acceleration. While high instrument costs remain a barrier, particularly for automated liquid handling and high-resolution imaging systems, emerging markets such as China and India offer lucrative opportunities with strong government support and an expanding pharmaceutical manufacturing base. Who Are the Key Stakeholders? The HTS ecosystem spans pharmaceutical giants, biotechnology innovators, academic institutions, and technology providers, all collaborating to enhance assay development and manage the rising complexity of biological data. The consumables segment—driven by recurring purchases of reagents and kits—dominates the market, ensuring steady demand as HTS workflows expand globally. Request Sample Pages: Where Is Growth Coming From? North America currently leads, fueled by advanced HTS infrastructure, robust funding for life science research, and a thriving biotech sector. Asia Pacific is projected to be the fastest-growing region, supported by a diverse patient base, strong pharmaceutical capabilities, and favorable regulatory environments. How Are Market Leaders Responding? Thermo Fisher Scientific Inc. maintains global leadership through an extensive portfolio of automated systems, screening instruments, and consumables, underpinned by 3% annual R&D investment and strategic alliances. Agilent Technologies, Inc. offers highly customizable workflows via BioTek detection instruments and Gen6 software, strengthened by acquisitions such as e-MSion (US) to enhance mass spectrometry capabilities. Merck KGaA delivers a diverse portfolio of reagents, instruments, software, and services, leveraging global reach and deep customer relationships across pharma, academia, and government sectors. Market Outlook As automation, AI-driven data analysis, and advanced assay development converge, HTS will remain at the forefront of pharmaceutical innovation. Decision-makers who strategically invest in HTS capabilities today will be best positioned to accelerate therapeutic pipelines, capture market share, and deliver faster, more targeted treatments to market. For more information, Inquire Now Discover Connected Healthcare Market Opportunities: Drug Screening Market Carrier Screening Market Cell based Assays Market Label Free Detection Market Life Science Instrumentation Market Get access to the latest updates on High-Throughput Screening Companies and High-Throughput Screening Market Size Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same. Ahmedabad Plane Crash GlobeNewswire provides press release distribution services globally, with substantial operations in North America and Europe.